Since the AR is activated by androgens, androgen deprivation therapy (ADT), which can be achieved either through surgical castration (orchiectomy) or chemical castration (using Gonadotropin-Releasing Hormone agonists or antagonists), is the mainstay treatment line for prostate cancer [3]. This evidence concerns the gene AR and prostate carcinoma.